The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome

Sahin Y. , Unluhizarci K. , Yılmazsoy A. , Yıkılmaz A. , Aygen E., Kelestimur F.

CLINICAL ENDOCRINOLOGY, cilt.67, sa.6, ss.904-908, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Konu: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1111/j.1365-2265.2007.02985.x
  • Dergi Adı: CLINICAL ENDOCRINOLOGY
  • Sayfa Sayıları: ss.904-908

Özet

Objective There are conflicting data regarding the effects of metformin in lean women with polycystic ovary syndrome (PCOS). Thus, our aim was to evaluate the effects of 6 months of metformin therapy on various metabolic and cardiovascular risk factors in lean women with PCOS.